Alemtuzumab ‐induced petechiae and epistaxis in a patient with relapsing–remitting multiple sclerosis: A case report

This study highlights such effects, emphasizing the need for vigilance as alemtuzumab usage increases. Timely recognition and management are vital for patient care.

Source: Clinical Case Reports - November 25, 2023 Category: General Medicine Authors: Farhad Mahmoudi, Sayed Ali Emami, Farid Masaeli, Najmeh Rayatpisheh Tags: CASE REPORT Source Type: research